VMD

Viemed Healthcare, Inc.

Healthcare · $347M market cap

Verdict

Share price

$9.13

close of Oct 3, 2026

Fair value

$3.54

Sticker Price

Payback Price

$1.42

buy price

Overpriced

VMD is Overpriced: at $9.13 it trades 158% above its fair value of $3.54. Its buy price (Payback Price) is $1.42, 84% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Justified P/B (Financials). It has earned a steady return on its equity for years, and its tangible assets are worth 23% of its share price. For a business like that, book value and the return on it are a sturdier guide than an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth7.7% a year✗
Equity per share growth12.1% a year✓
Sales growth24.5% a year✓
Free cash flow growth-3.7% a year✗
Return on invested capital8.5%✗

Follow VMD

Get notified when it reaches its buy price of $1.42. Free.

Create a free account

Superinvestors

1 of the investors we track holds VMD. Who we track

Insider activity

Since Jun 24, 2026: no open-market purchases, 6 sales worth $347K and 17 other filings (stock awards, tax withholding and similar). Why purchases matter

Sales

Other filings

About Viemed Healthcare, Inc.

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and…

Medical - Care Facilities

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

VMD stock (Viemed Healthcare, Inc.): fair value $3.54, Overpriced — PaybackPrice